info@marketresearchfuture.com   ๐Ÿ“ž +1 (855) 661-4441(US)   ๐Ÿ“ž +44 1720 412 167(UK)   ๐Ÿ“ž +91 2269738890(APAC)
Certified Global Research Member
Isomar 1 Iso 1
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Branched Stent Graft Market Research Report By Device Type (Aortic Branched Stent Grafts, Iliac Branched Stent Grafts, Femoral Branched Stent Grafts), By Material (Nitinol, Polytetrafluoroethylene (PTFE), Polyester), By Endovascular Access (Transfemoral, Transradial, Subclavian) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Forecast to 2034


ID: MRFR/HC/29371-HCR | 128 Pages | Author: Rahul Gotadki| August 2025

Branched Stent Graft Market Overview

As per MRFR analysis, the Branched Stent Graft Market Size was estimated at 2.22 (USD Billion) in 2024. The Branched Stent Graft Market Industry is expected to grow from 2.39 (USD Billion) in 2025 to 4.78 (USD Billion) till 2034, at a CAGR (growth rate) is expected to be around 7.98% during the forecast period (2025 - 2034).

Key Branched Stent Graft Market Trends Highlighted

ย The use of advanced imaging techniques and procedural planning tools is also gaining traction, enabling more precise and efficient interventions. Moreover, the growth of robotic-assisted procedures and the integration of artificial intelligence in stent graft design offer promising avenues for market expansion.Opportunities can be explored in the development of tailored devices for specific anatomical variations, addressing unmet clinical needs. Additionally, the expansion of markets in emerging economies and the increasing awareness of endovascular therapies among patients and healthcare providers present lucrative avenues for market penetration.

Branched Stent Graft Market Overview

Source Primary Research, Secondary Research, Market Research Future Database and Analyst Review

Branched Stent Graft Market Drivers

Rising Prevalence of Cardiovascular Diseases

Cardiovascular diseases, including heart attacks and strokes, are a major cause of mortality and morbidity worldwide. The increasing prevalence of these diseases is a key driver of the growth of the branched stent graft market. Branched stent grafts are used to treat aortic aneurysms, a condition in which the aorta, the body's largest artery, becomes enlarged and weakened. As the population ages, the incidence of aortic aneurysms is expected to increase, further driving the demand for branched stent grafts.ย The rising prevalence of cardiovascular diseases is attributed to several factors, including unhealthy lifestyles, such as smoking, unhealthy diet, and lack of physical activity. Additionally, the increasing prevalence of diabetes and obesity contributes to the development of cardiovascular diseases.

ย As a result, the demand for branched stent grafts is expected to increase in the coming years. According to the World Health Organization (WHO), cardiovascular diseases are the leading cause of death globally, accounting for an estimated 17.9 million deaths in 2019.The WHO projects that the number of deaths from cardiovascular diseases will continue to rise in the coming years, reaching 23.6 million by 2030. The increasing prevalence of cardiovascular diseases is a major concern for healthcare systems worldwide. Branched stent grafts offer a minimally invasive and effective treatment option for aortic aneurysms, which can help to improve patient outcomes and reduce the burden on healthcare systems.

Technological Advancements

The Branched Stent Graft Market Industry has witnessed significant technological advancements in recent years. These advancements have led to the development of more effective and less invasive branched stent grafts. For instance, the introduction of self-expanding branched stent grafts has eliminated the need for open surgery, which has reduced patient recovery time and improved outcomes. Additionally, advancements in imaging techniques, such as computed tomography (CT) and magnetic resonance imaging (MRI), have improved the accuracy of stent graft placement.This has led to better patient outcomes and reduced the risk of complications.ย 

The continuous development of new and improved branched stent grafts is expected to drive the growth of the market in the coming years. Researchers are exploring the use of new materials and designs to improve the performance and durability of branched stent grafts. These advancements are expected to further expand the applications of branched stent grafts and improve patient outcomes.

Growing Awareness and Acceptance of Endovascular Procedures

Endovascular procedures are less invasive than traditional open surgery and offer several advantages, including reduced recovery time, less pain, and fewer complications. As a result, there has been a growing awareness and acceptance of endovascular procedures among both patients and physicians. Branched stent grafts are an important part of endovascular procedures used to treat aortic aneurysms. The increasing acceptance of endovascular procedures is expected to drive the demand for branched stent grafts in the coming years.ย 

To promote awareness and acceptance of endovascular procedures, several initiatives have been undertaken by healthcare organizations and professional societies. These initiatives include educational campaigns, conferences, and workshops. The aim of these initiatives is to educate patients and physicians about the benefits of endovascular procedures and to encourage their use.

Branched Stent Graft Market Segment Insights

Branched Stent Graft Market Device Type Insights

The Branched Stent Graft Market segmentation by Device Type can be divided into Aortic Branched Stent Grafts, Iliac Branched Stent Grafts, and Femoral Branched Stent Grafts. Among these, Aortic Branched Stent Grafts held the largest market share in 2023, and is expected to maintain its dominance throughout the forecast period. The growth of this segment can be attributed to the rising prevalence of aortic aneurysms and the increasing adoption of endovascular repair techniques. Iliac Branched Stent Grafts are expected to witness a significant growth rate during the forecast period.This growth can be attributed to the increasing number of minimally invasive procedures being performed for the treatment of iliac artery aneurysms and occlusive diseases. The growth of the market is attributed to the increasing prevalence of aortic aneurysms, iliac artery aneurysms, and peripheral artery disease, as well as the rising adoption of endovascular repair techniques.

Branched Stent Graft Market Device Type Insights

Source Primary Research, Secondary Research, Market Research Future Database and Analyst Review

Branched Stent Graft Market Material Insights

The Branched Stent Graft Market is segmented based on material into Nitinol, Polytetrafluoroethylene (PTFE), and Polyester. In 2023, the Nitinol segment held the largest market share of around 65%, owing to its excellent biocompatibility, flexibility, and strength. It is used in the manufacturing of stents and stent grafts for the treatment of aortic aneurysms and dissections. The PTFE segment is expected to witness significant growth over the forecast period due to its high durability, low friction coefficient, and resistance to kinking.It is commonly used in the production of vascular grafts for peripheral artery disease and hemodialysis access. The Polyester segment is gaining traction in the market as it offers high tensile strength and resistance to tear. It is primarily used in the manufacturing of stent grafts for the treatment of abdominal aortic aneurysms.

Branched Stent Graft Market Endovascular Access Insights

The Branched Stent Graft Market is segmented based on endovascular access into Transfemoral, Transradial, and Subclavian. In 2023, the Transfemoral segment accounted for the largest share of the market, owing to its wide acceptance and established techniques. However, the Transradial segment is projected to grow at a higher CAGR during the forecast period, due to its advantages such as reduced bleeding complications and improved patient comfort. The Subclavian segment is expected to witness a steady growth, supported by the increasing adoption of minimally invasive endovascular procedures.

Branched Stent Graft Market Regional Insights

The regional segmentation of the Branched Stent Graft Market presents distinct market dynamics and growth opportunities. North America dominates the market with a significant share, driven by factors such as advanced healthcare infrastructure, high prevalence of cardiovascular diseases, and favorable reimbursement policies. Europe follows closely, with a well-established healthcare system and a large patient population.ย 

The Asia-Pacific (APAC) region is expected to witness substantial growth due to rising disposable incomes, increasing healthcare expenditure, and growing awareness about cardiovascular health.South America and the Middle East and Africa (MEA) regions offer emerging markets with untapped potential for market expansion. Overall, the Branched Stent Graft Market is witnessing robust growth, with key players focusing on strategic partnerships, product innovations, and geographical expansion to capitalize on these regional market opportunities. In 2024, the Branched Stent Graft Market revenue is projected to reach USD 2.1 billion, with a CAGR of 8.5% from 2024 to 2032.

Branched Stent Graft Market Regional Insights

Source Primary Research, Secondary Research, Market Research Future Database and Analyst Review

Branched Stent Graft Market Key Players And Competitive Insights

Major players in Branched Stent Graft Market industry are focused on developing innovative products and expanding their reach. Leading Branched Stent Graft Market players are investing heavily in research and development to introduce advanced products that meet the evolving needs of patients and healthcare providers. Partnerships and collaborations among industry participants are also driving Branched Stent Graft Market development, enabling the sharing of expertise and resources.

ย The Competitive Landscape of the Branched Stent Graft Market is characterized by intense competition among established players and emerging entrants. Top players are leveraging their strong distribution networks and brand recognition to maintain their market positions, while smaller companies are focusing on niche markets and cost-effective solutions to gain a competitive edge.

Medtronic is a leading company in the Branched Stent Graft Market, offering a comprehensive portfolio of branched stent grafts for the treatment of complex aortic aneurysms. The company's Endurant II and Valiant Captivia Stent Grafts are widely recognized for their excellent clinical outcomes and durability. Medtronic's strong presence, established distribution channels, and commitment to innovation have contributed to its leadership position in the market.ย 

The company is actively involved in research and development to enhance the performance and functionality of its products, ensuring its continued competitiveness in the face of evolving market dynamics.Boston Scientific is another prominent player in the Branched Stent Graft Market, known for its innovative product offerings and strong market presence.ย 

The company's Zenith Alpha and Zenith TX2 Stent Grafts are highly regarded for their advanced features and versatility in treating complex aortic pathologies. Boston Scientific's commitment to clinical research and collaboration with leading medical centers has enabled it to develop differentiated products that meet the specific needs of patients. The company's extensive distribution network and established relationships with healthcare providers have been instrumental in its success in the Branched Stent Graft Market.

Key Companies in the Branched Stent Graft Market Include

    • Terumo Aortic
    • ev3
    • L Medical
    • L. Gore Associates
    • Shenzhen Margin Medical
    • Boston Scientific
    • Cook Medical
    • Stryker
    • EndoVascular Technologies
    • Gore Medical
    • Jotec
    • Medtronic
    • A Medical
    • Convatec

Branched Stent Graft Market Industry Developments

  • Q2 2024: Endologix Announces FDA Approval of DETOUR2 System for Treatment of Complex Peripheral Arterial Disease Endologix received FDA approval for its DETOUR2 System, a device designed for complex peripheral arterial disease, which includes branched stent graft technology. The approval marks a significant regulatory milestone for the company in the U.S. market.
  • Q1 2024: Cook Medical Launches Zenith Fenestrated+ Endovascular Graft in Europe Cook Medical announced the commercial launch of its Zenith Fenestrated+ Endovascular Graft in select European markets. The device is designed for complex aortic aneurysms and features branched and fenestrated stent graft technology.
  • Q2 2024: Terumo Aortic Receives CE Mark for RelayBranch Thoracic Stent-Graft System Terumo Aortic obtained CE Mark approval for its RelayBranch Thoracic Stent-Graft System, enabling commercial sales in Europe. The device is intended for the treatment of aortic arch pathologies using branched stent graft technology.
  • Q2 2024: Medtronic Announces First Patient Treated in U.S. Pivotal Study of Valiant TAAA Stent Graft System Medtronic began its U.S. pivotal clinical trial for the Valiant TAAA Stent Graft System, a branched stent graft designed for thoracoabdominal aortic aneurysms. The first patient was successfully treated in the study.
  • Q1 2024: Boston Scientific Completes Acquisition of Relievant Medsystems Boston Scientific completed the acquisition of Relievant Medsystems, expanding its portfolio in minimally invasive vascular therapies, including branched stent graft solutions for complex aortic disease.
  • Q2 2024: Terumo Aortic Opens New Manufacturing Facility in Scotland Terumo Aortic inaugurated a new manufacturing facility in Scotland to increase production capacity for its branched and fenestrated stent grafts, supporting global demand and innovation.
  • Q1 2024: Gore Medical Receives FDA Breakthrough Device Designation for New Branched Endoprosthesis Gore Medical was granted FDA Breakthrough Device Designation for its new branched endoprosthesis, designed to treat complex aortic arch aneurysms with advanced stent graft technology.
  • Q2 2024: Medtronic Launches Valiant Navion Thoracic Stent Graft in Japan Medtronic launched the Valiant Navion Thoracic Stent Graft in Japan, expanding its global reach for branched stent graft solutions targeting thoracic aortic disease.
  • Q1 2024: Endologix Announces Strategic Partnership with Artivion for Distribution of Branched Stent Grafts in Europe Endologix entered into a strategic partnership with Artivion to distribute its branched stent graft products across European markets, aiming to enhance access to advanced endovascular solutions.
  • Q2 2024: Cook Medical Receives FDA Approval for Zenith Branch Thoracoabdominal Endovascular Graft Cook Medical received FDA approval for its Zenith Branch Thoracoabdominal Endovascular Graft, a device designed for the treatment of thoracoabdominal aortic aneurysms using branched stent graft technology.
  • Q1 2024: Gore Medical Expands Manufacturing Operations in Arizona Gore Medical expanded its manufacturing operations in Arizona to support increased production of its branched stent graft products, addressing rising global demand.
  • Q2 2024: Boston Scientific Appoints New Head of Vascular Interventions Division Boston Scientific appointed a new executive to lead its Vascular Interventions Division, which oversees the development and commercialization of branched stent graft technologies.

Branched Stent Graft Market Segmentation Insights

    • Branched Stent Graft Market Device Type Outlook

      • Aortic Branched Stent Grafts
      • Iliac Branched Stent Grafts
      • Femoral Branched Stent Grafts
    • Branched Stent Graft Market Material Outlook

      • Nitinol
      • Polytetrafluoroethylene (PTFE)
      • Polyester
    • Branched Stent Graft Market Endovascular Access Outlook

      • Transfemoral
      • Transradial
      • Subclavian
    • Branched Stent Graft Market Regional Outlook

      • North America
      • Europe
      • South America
      • Asia Pacific
      • Middle East and Africa
Report Attribute/Metric Details
Market Size 2024 ย ย  2.22 (USD Billion)
Market Size 2025 ย ย  2.39 (USD Billion)
Market Size 2034 ย ย  4.78 (USD Billion)
Compound Annual Growth Rate (CAGR) ย ย  7.98 % (2025 - 2034)
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
Base Year 2024
Market Forecast Period 2025 - 2034
Historical Data 2020 - 2024
Market Forecast Units USD Billion
Key Companies Profiled Terumo Aortic, ev3, Microport, L Medical, W. L. Gore Associates, Shenzhen Margin Medical, Boston Scientific, Cook Medical, Stryker, EndoVascular Technologies, Gore Medical, Jotec, Medtronic, A Medical, Convatec
Segments Covered Device Type, Material, Endovascular Access, Regional
Key Market Opportunities Increased prevalence of aortic aneurysms Technological advancements Rising demand for minimally invasive procedures Growing awareness Expanding indications for branched stent grafts
Key Market Dynamics Increased prevalence of aortic aneurysms Technological advancements Rising demand for minimally invasive procedures Growing geriatric population Favorable reimbursement policies
Countries Covered North America, Europe, APAC, South America, MEA


Frequently Asked Questions (FAQ):

The Branched Stent Graft Market is expected to be valued at USD 1.9 billion in 2023.

The Branched Stent Graft Market is expected to grow at a CAGR of 7.98% from 2025 to 2034.

North America is expected to hold the largest share of the Branched Stent Graft Market in 2023.

The endovascular repair of abdominal aortic aneurysms (AAA) is expected to drive the growth of the Branched Stent Graft Market.

The key competitors in the Branched Stent Graft Market include Medtronic, Cook Medical, Terumo, Jotec, and Bolton Medical.

The Branched Stent Graft Market is expected to be valued at USD 4.78 billion in 2034.

Asia Pacific is expected to grow at the highest CAGR in the Branched Stent Graft Market from 2025 to 2034.

The key factors driving the growth of the Branched Stent Graft Market include the increasing prevalence of aortic aneurysms, the rising adoption of endovascular repair techniques, and the growing demand for minimally invasive procedures.

The challenges faced by the Branched Stent Graft Market include the high cost of branched stent grafts, the risk of complications associated with endovascular repair procedures, and the limited availability of skilled surgeons.

The opportunities for growth in the Branched Stent Graft Market include the development of new and improved branched stent grafts, the expansion of endovascular repair techniques into new markets, and the growing demand for minimally invasive procedures.

Comments

Leading companies partner with us for data-driven Insights.

clients

Kindly complete the form below to receive a free sample of this Report

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.
report-img